A Review on the Relationship between SGLT2 Inhibitors and Cancer

Risk of increasing breast and bladder cancer remains a safety issue of SGLT2 (sodium glucose cotransporter type 2) inhibitors, a novel class of antidiabetic agent. We reviewed related papers published before January 29, 2014, through Pubmed search. Dapagliflozin and canagliflozin are the first two a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hao-Wen, Tseng, Chin-Hsiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164126/
https://www.ncbi.nlm.nih.gov/pubmed/25254045
http://dx.doi.org/10.1155/2014/719578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164126/
https://www.ncbi.nlm.nih.gov/pubmed/25254045
http://dx.doi.org/10.1155/2014/719578

Ejemplares similares